The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Kenneth A. Jamerson

Division of Cardiovascular Medicine

Ann Arbor

MI 48106

USA

[email]@umich.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Cardiovascular Medicine, Ann Arbor, MI 48106, USA. 2000 - 2011
  • Department of Internal Medicine, University of Michigan Health Systems, 3918 Taubman Center, Box 0356, USA. 2004 - 2008
  • University of Michigan Health System, Division of Cardiovascular Medicine, Ann Arbor, Michigan 48106-0739, USA. 2007

References

  1. Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control. Jamerson, K.A., Devereux, R., Bakris, G.L., Dahlöf, B., Pitt, B., Velazquez, E.J., Weir, M., Kelly, R.Y., Hua, T.A., Hester, A., Weber, M.A. Hypertension (2011) [Pubmed]
  2. Prompt, aggressive BP lowering in high-risk patients. Jamerson, K.A., Basile, J. J. Clin. Hypertens. (Greenwich) (2008) [Pubmed]
  3. Exceptional early blood pressure control rates: the ACCOMPLISH trial. Jamerson, K., Bakris, G.L., Dahlöf, B., Pitt, B., Velazquez, E., Gupte, J., Lefkowitz, M., Hester, A., Shi, V., Kjeldsen, S.E., Cushman, W., Papademetriou, V., Weber, M. Blood Press. (2007) [Pubmed]
  4. Preventing chronic kidney disease in special populations. Jamerson, K.A. Am. J. Hypertens. (2005) [Pubmed]
  5. The disproportionate impact of hypertensive cardiovascular disease in African Americans: getting to the heart of the issue. Jamerson, K.A. J. Clin. Hypertens. (Greenwich) (2004) [Pubmed]
  6. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson, K.A., Nwose, O., Jean-Louis, L., Schofield, L., Purkayastha, D., Baron, M. Am. J. Hypertens. (2004) [Pubmed]
  7. The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH). Jamerson, K.A. J. Clin. Hypertens. (Greenwich) (2003) [Pubmed]
  8. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. Jamerson, K.A. Am. J. Kidney Dis. (2000) [Pubmed]
 
WikiGenes - Universities